PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1935235
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1935235
Medical Oxygen Systems Market is estimated to be valued at USD 5.20 Bn in 2026 and is expected to reach USD 8.40 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.20 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.20% | 2033 Value Projection: | USD 8.40 Bn |
Medical oxygen is required in various surgical recovery processes such as prevention of oxygen deficiency in body during surgery, major traumatic medical conditions such as accidents, heart attack, blood loss, hyperpyrexia, severe lung conditions as well as for treatment of cluster headache, and for resuscitation. Furthermore, medical oxygen is administered to the patients while giving anesthesia. Medical oxygen is only prescribed by healthcare professionals.
Medical oxygen is delivered to the patients by using various oxygen delivery systems such as compressed cylinders, concentrators, and centralized oxygen cylinders, mainly for hospital use. Advancements in technology in oxygen systems is expected to create an opportunity for manufacturers to produce Hi-tech products with multiple functionality. For instance, Inogen, Invacare Corporation offers the portable oxygen concentrator with connectivity to operate medical oxygen system wireless.
Increasing product launches for medical oxygen systems is expected to drive growth of the global medical oxygen systems market. For instance, In January 2018, ResMed Inc. launched Mobi, its first ResMed-branded portable oxygen concentrator (POC). Mobi offers efficient oxygen delivery and battery life and is used in Chronic Obstructive Pulmonary Disease (COPD) and other respiratory conditions. Moreover, in 2017, GCE Healthcare launched its Zen-O lite portable oxygen concentrator. This new portable oxygen concentrator is designed to help people with respiratory disorders such as COPD.
Moreover, increasing prevalence of pulmonary disorders, which may result in high demand for medical oxygen systems is expected to be the major driver for growth of the global medical oxygen systems market. For instance, according to the World Health Organization's estimation report, in December 2017, around 251 million cases of COPD were diagnosed worldwide in 2016.
Key features of the study